title: Hyperparathyroidism: cancer and mortality.
abstract: Hyperparathyroidism is a commoner endocrinopathy today with a large number of asymptomatic patients in contrast to the scenario five decades ago. Surgery is indicated for patients fulfilling the NIH criteria who are mostly symptomatic while individuals with mild disease are managed conservatively. Several studies indicate increased risk of malignancy involving several sites and related mortality in primary hyperparathyroidism (PHPT) with the risk persisting for several years after surgery. PHPT is associated with structural & functional cardiac abnormalities and premature death from increased cardiovascular disease with risk normalising only several years after surgery. Mortality risk is associated with pre-operative serum calcium & parathormone and parathyroid adenoma weight. However, the issue of existence of similar risk and surgical benefit in mild PHPT is mired in controversy although some studies have shown an association and beneficial trends with surgery. With current evidence, it would be prudent to follow up PHPT patients for malignancy and cardiovascular disease and possibly adopt a more liberal attitude towards surgery.
authors.affiliation: Department of Endocrinology and Metabolism, Institute of Post Graduate Medical Education and Research, Kolkata, India.
authors.forename: Soumik
authors.initials: S
authors.lastname: Goswami
authors.forename: Sujoy
authors.initials: S
authors.lastname: Ghosh
keywords: Hyperparathyroidism; cancer; mortality
references.citation: Eur J Clin Invest. 1998 Apr;28(4):271-6
references.pmid: 9615902
references.citation: Am J Med. 1998 Feb;104(2):115-22
references.pmid: 9528728
references.citation: Eur Heart J. 2004 Oct;25(20):1776-87
references.pmid: 15474692
references.citation: Surgery. 1995 Feb;117(2):134-9
references.pmid: 7846616
references.citation: World J Surg. 2000 May;24(5):564-9; discussion 569-70
references.pmid: 10787077
references.citation: Cancer. 2002 Oct 15;95(8):1611-7
references.pmid: 12365007
references.citation: J Clin Endocrinol Metab. 1948 Aug;8(8):637-57
references.pmid: 18877062
references.citation: N Engl J Med. 2000 Dec 21;343(25):1863-75
references.pmid: 11117980
references.citation: World J Surg. 2004 Jan;28(1):108-11
references.pmid: 14648050
references.citation: Surgery. 2001 Dec;130(6):978-85
references.pmid: 11742326
references.citation: Endocr Relat Cancer. 2007 Mar;14(1):135-40
references.pmid: 17395982
references.citation: Cancer Causes Control. 2007 Aug;18(6):595-602
references.pmid: 17410477
references.citation: Am J Epidemiol. 1988 May;127(5):1031-40
references.pmid: 3358404
references.citation: World J Surg. 1990 Nov-Dec;14(6):829-35; discussion 836
references.pmid: 2256355
references.citation: Surgery. 1987 Jul;102(1):1-7
references.pmid: 3589970